The Management of Degenerative Complete Heart Block in the Time of Coronavirus
Published: 2022-09-03
Page: 273-279
Issue: 2022 - Volume 5 [Issue 1]
Jaouad Nguadi
Rhythmology Department, Cardiology Center, Mohammed V Military Instruction Hospital of Rabat, Mohammed V University, Morocco.
Meryem Bennani
Rhythmology Department, Cardiology Center, Mohammed V Military Instruction Hospital of Rabat, Mohammed V University, Morocco.
Youssef Lahmouz *
Clinical Cardiology Department, Cardiology Center, Mohammed V Military Instruction Hospital of Rabat, Mohammed V University, Morocco.
Zaynab Mouhib
Clinical Cardiology Department, Cardiology Center, Mohammed V Military Instruction Hospital of Rabat, Mohammed V University, Morocco.
Abdelilah Benelmekkki
Rhythmology Department, Cardiology Center, Mohammed V Military Instruction Hospital of Rabat, Mohammed V University, Morocco.
Najat Mouine
Clinical Cardiology Department, Cardiology Center, Mohammed V Military Instruction Hospital of Rabat, Mohammed V University, Morocco.
Hicham Bouzelmat
Rhythmology Department, Cardiology Center, Mohammed V Military Instruction Hospital of Rabat, Mohammed V University, Morocco.
Ali Chaib
Rhythmology Department, Cardiology Center, Mohammed V Military Instruction Hospital of Rabat, Mohammed V University, Morocco.
Aatif Benyass
Mohammed V Military Instruction Hospital of Rabat, Mohammed V University, Morocco.
*Author to whom correspondence should be addressed.
Abstract
The use of chloroquine for SARS COV2 has been adopted by many countries around the world, including Morocco. The Chloroquine is known for its anti-arrhythmic and bradycardic effects and for its formal contraindication in cardiac conduction disorders, long QT and high-degree heart block, which makes the management of a complete heart block in a positive Covid a great dilemma for the rhythmologist. In this article, we describe the management of the association COVID 19-symptomatic high-degree heart block.
Keywords: Chloroquine, COVID-19, complete heart block
How to Cite
References
Circulaire Du Ministere De Santé Marocain du 23 mars (sante.gov.ma)
Available :https://www.who.int/emergencies/diseases/novel-coronavirus-2019/ situation-reports.
Statistiques relatives au coronavirus - Bing
Devaux CA, Rolain JM, Colson P, Raoult D. New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? Int J Antimicrob Agents. 2020;55: 105938.
Perez BC, Fernandes I, Mateus N, Teixeira C, Gomes P. Recycling antimalarial leads for cancer: antiproliferative properties of N-cinnamoyl chloroquine analogues. Bioorg Med Chem Lett. 2013;23:6769–72.
Plantone D, Koudriavtseva T. Current and future use of chloroquine and hydroxychloroquine in infectious, immune, neoplastic, and neurological diseases: a mini-review. Clin Drug Investig. 2018; 38:653–71.
Coronavirus: Pays où l’hydroxychloroquine est recommandée – IHU (mediterranee-infection.com)
Clotilde Chatre, François Roubille, Hélène Vernhet, Christian Jorgensen; Yves-Marie Pers. Cardiac Complications Attributed to Chloroquine and Hydroxychloroquine: A Systematic Review of the Literature.
Costedoat- Chalumeau JS, Hulot Z, Amoura G, Leroux P, Lechat C. Funck-Brentano JC. Heart conduction disorders related to antimalarials toxicity: an analysis of electrocardiograms in 85 patients treated with hydroxychloroquine for connective tissue diseases N. Piette Rheumatology. 2007;46(5):808–810.
Reinhard Kandolf, Thorsten Lewalter. Chloroquine Cardiomyopathy – A Review of the Literature Ernst Tönnesmann. 2013: 434-442.
Accepted 22 Feb 2013,
Published online: 01 May 2013.
Available:https://doi.org/10.3109/08923973.2013.780078
Cardiac effects and toxicity of chloroquine: a short update Kanigula Mubagwaa, Department of Cardiovascular Sciences, KU Leuven, Leuven, Belgium Department of Basic Sciences, Faculty of Medicine, Université Catholique de Bukavu, Bukavu, DR Congo.
Essien EE, Andy JJ. Complete Heart Block in Chronic Chloroquine Poisoning; Ladipo GOA.
Omar Al-assaf, Madiha Mirza, Anas Musa. Atypical presentation of COVID-19 as subclinical myocarditis with persistent high-degree atrioventricular block treated with pacemaker implant. From the Internal Medicine Department, Rashid Hospital, Dubai Health Authority, Dubai, United Arab Emirates, and Cardiology Department, Rashid Hospital, Dubai Health Authority, Dubai, United Arab Emirates.